Skip to main content

WATSON 395 50 0 .5 Pill - green oval, 13mm

Pill with imprint WATSON 395 50 0 .5 is Green, Oval and has been identified as Naloxone Hydrochloride and Pentazocine Hydrochloride 0.5 mg / 50 mg. It is supplied by Watson Pharmaceuticals.

Naloxone/pentazocine is used in the treatment of Chronic Pain; Pain and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Naloxone/pentazocine 0.5 mg / 50 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 395 50 0 .5

Naloxone hydrochloride and pentazocine hydrochloride 0.5 mg / 50 mg WATSON 395 50 0 .5
Naloxone hydrochloride and pentazocine hydrochloride 0.5 mg / 50 mg WATSON 395 50 0 .5 Front
Naloxone hydrochloride and pentazocine hydrochloride 0.5 mg / 50 mg WATSON 395 50 0 .5 Back
Naloxone hydrochloride and pentazocine hydrochloride 0.5 mg / 50 mg WATSON 395 50 0 .5

Naloxone Hydrochloride and Pentazocine Hydrochloride

Imprint
WATSON 395 50 0 .5
Strength
0.5 mg / 50 mg
Color
Green
Size
13.00 mm
Shape
Oval
Availability
Prescription only
Drug Class
Narcotic analgesic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Pharmaceuticals
Inactive Ingredients
silicon dioxide, calcium phosphate dibasic anhydrous, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Yellow No. 6, magnesium stearate, microcrystalline cellulose, corn starch, sodium lauryl sulfate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-0395 Watson Pharmaceuticals, Inc.
35356-0176 (Discontinued) Lake Erie Medical and Surgical Supply (repackager)
43063-0142 (Discontinued) PDRX Pharmaceuticals Inc. (repackager)
63874-0220 (Discontinued) Altura Pharmaceuticals Inc. (repackager)
66267-0487 (Discontinued) Nucare Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.